InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Kenkare-Mitra Sara, Président et Responsable de la R&D. Director active across 1 companies, notably Alector, Inc.. Aggregated, 2 filings have been logged. The latest transaction was filed on 3 January 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations2 total
059,000 shares0
Common Stock
SEC:0001209191-22-001791·
059,000 shares0
Common Stock
SEC:0001209191-22-001791:0·
2 of 2 declarations
About Kenkare-Mitra Sara
Sara Kenkare-Mitra is the President and Head of Research and Development at Alector, Inc. She leads the company's research and development initiatives, focusing on innovation and scientific advancement. Sara plays a key role in the strategy for developing new treatments, thereby contributing to Alector's mission. Her expertise in R&D is essential for the company's success.
